In fact, when the PD-1 on activated CD8+ T cells interacts with its corresponding ligands on antigen presenting cells and/or tumor cells, T cell receptor (TCR) signaling is attenuated, resulting in reduced T cell effector functions in a process that ultimately generates exhaustion [11]. The gene discussed is CD8A; the disease is neoplasm.